| Affiliation: | 1. Hudson College of Public Health, University of Oklahoma Health Sciences Center, Schusterman Center, Tulsa OK, USA;2. Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA) Division of Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, USA;3. Children''s National Hospital, Washington, DC, USA;4. Friends Research Institute, Baltimore, MD, USA;5. Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA;6. Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA;7. Center for Addiction Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA;1. Department of Psychology, Emma Eccles Jones College of Education and Human Services, Utah State University, Logan, USA;2. Department of Psychological Medicine, University of Auckland, Auckland City Hospital, 2 Park Road, Grafton, Auckland, 1142, New Zealand;1. Département de pharmacologie et physiologie, Université de Montréal, Montréal, QC, Canada;2. Centre de Recherche de l’Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada;3. Service de néphrologie, CIUSSS de l’Est-de-l’Île-de-Montréal, Montréal, QC, Canada;4. Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada;1. Dentistry Postgraduate Research Program, Rio de Janeiro State University, Rio de Janeiro, Brazil;2. H&TRC- Health & Technology Research Center, ESTeSL- Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, Lisbon, Portugal;3. Pharmaceutical Sciences Postgraduate Research Program, Federal University of Paraná, Curitiba, Brazil;4. Department of Pharmaceutical Sciences, Federal Rural University of Rio de Janeiro, Seropedica, Brazil;1. Pharmacy and Pharmaceutical Technology Department, Faculty of Pharmacy, University of Granada, Granada, Spain;2. School of Medical and Health Sciences, Bangor University, Bangor, Gwynedd, UK;3. Department of Preventive Medicine and Public Health, University of Zaragoza, Zaragoza, Spain;4. Grupo de Investigación en Servicios Sanitarios de Aragón (GRISSA), Fundación Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain;5. Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), ISCIII, Madrid, Spain;6. Pharmaceutical Care Research Group, Faculty of Pharmacy, University of Granada, Granada, Spain;1. Geisinger/Prime Med, 790 Northern Blvd. Suite L, Clarks Summit, PA, 18411, USA;2. Geisinger Medical Center, 100 N Academy Avenue, Danville, PA, 17822, USA;3. Geisinger Telepharmacy, 58-60 Public Square, Wilkes-Barre, PA, 18701, USA;4. Geisinger 65 Forward State College, 293 Patriot Lane, State College, PA, 16803, USA;5. Wilkes University Nesbitt School of Pharmacy, 84 West South Street, Wilkes-Barre, PA, 18766, USA;1. Divison of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA;2. Division of Research, UNC Health Sciences at MAHEC, Asheville, NC, USA;3. Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA;4. Division of Global Health and Infectious Disease, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA |
